这项战略合作将整合Solid的载体生物学、制造能力和药物开发经验,以及Phlox在遗传心肌病和RNA治疗方面的专业知识。
两家公司表示,...查看全文
牛唐2022-10-03 15:50
医药板块速评(2022.09.30)
本期内容提示:
1、美股大盘跌跌不休,是否有抄底机会?$纳指100ETF-Invesco(QQQ)$
2、$Solid Biosciences(SLDB)、$Valneva SE(VALN)增发,是否有机会跟仓?
3、$贝壳(BEKE)$ 、$创新ETF-ARK(ARKK)$ 、$Twitter(TWTR)、$中概互联网指数ETF-KraneShares...查看全文
美股滚雪球2022-10-02 22:24
$Solid Biosciences(SLDB)$ 宣布收购基因治疗公司AavantiBio,旨在推进一系列神经肌肉和心脏项目,预计四季度完成合并。
交易完成后,AavantiBio现任首席执行官Bo Cumbo将担任Solid Biosciences的总裁兼首席执行官。
为支持此次收购,SLDB已与一些选定的机构投资者和合格投资者达成了一项...查看全文
chuminhua2021-09-24 11:43
9月23日,Solid Biosciences公司公布了它所描述的杜氏肌营养不良症(DMD)患者的 "积极 "更新结果,这三名患者正在进行IGNITE DMD研究,评估SGT-001,其实验性AAV基因转移疗法。周四在World Muscle Society (WMS)大会上公布的研究结果提供了 "令人鼓舞的证据,与自然史数据相比,治...查看全文
$Solid Biosciences(SLDB)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-08-02 AccNo: 0000935836-19-000407 Size: 48 KB 网页链接
$Solid Biosciences(SLDB)$ D - Notice of Exempt Offering of Securities Filed: 2019-07-31 AccNo: 0001707502-19-000002 Size: 19 KB 网页链接
$Solid Biosciences(SLDB)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-07-30 AccNo: 0001193125-19-207100 Size: 39 KB 网页链接
$Solid Biosciences(SLDB)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-07-30 AccNo: 0001144204-19-036692 Size: 48 KB 网页链接
$Solid Biosciences(SLDB)$ 8-K - Current report Filed: 2019-07-26 AccNo: 0001193125-19-204157 Size: 397 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits ...
$Solid Biosciences(SLDB)$ 8-K - Current report Filed: 2019-06-14 AccNo: 0001193125-19-173665 Size: 24 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Solid Biosciences(SLDB)$ 8-K - Current report Filed: 2019-05-13 AccNo: 0001193125-19-145404 Size: 72 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Solid Biosciences(SLDB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-13 AccNo: 0001564590-19-018869 Size: 5 MB 网页链接
$Solid Biosciences(SLDB)$ DEF 14A - Other definitive proxy statements Filed: 2019-05-03 AccNo: 0001140361-19-008386 Size: 3 MB 网页链接
$Solid Biosciences(SLDB)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-05-03 AccNo: 0001140361-19-008388 Size: 370 KB 网页链接